Raymond James Financial
GDRX icon

Raymond James Financial’s GoodRx Holdings GDRX Stock Holding History

Raymond James Financial’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Buy
141,600
+16,735
+13% +$39.3K ﹤0.01% 4699
2025
Q4 		$338K Sell
124,865
-183,876
-60% -$604K ﹤0.01% 4495
2025
Q3 		$1.31M Sell
308,741
-443,234
-59% -$1.95M ﹤0.01% 3509
2025
Q2 		$3.74M Sell
751,975
-78,975
-10% -$343K ﹤0.01% 2575
2025
Q1 		$3.66M Buy
830,950
+293,420
+55% +$1.38M ﹤0.01% 2536
2024
Q4 		$2.5M Buy
+537,530
New +$2.95M ﹤0.01% 2812

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Raymond James Financial's GDRX Position: Q1 2026 in Review

Raymond James Financial increased its GoodRx Holdings (GDRX) stake by 13% in Q1 2026, buying an estimated $39.3K and bringing the position to 141,600 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #4699.

Raymond James Financial first reported a position in GDRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.74M in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Raymond James Financial held 141,600 shares of GoodRx Holdings worth $278K as of Q1 2026.
  • Raymond James Financial bought 16,735 GoodRx Holdings shares in Q1 2026, an estimated $39.3K.
  • GoodRx Holdings made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4699 holding.
  • Raymond James Financial first reported a position in GoodRx Holdings in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's GoodRx Holdings position peaked at $3.74M in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.